About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDPhase 1

Safety of an HIV DNA Vaccine Given to HIV Uninfected Adults

A Phase I Trial to Evaluate the Safety and Immunogenicity of the HIV-1 pGA2/JS2 Plasmid DNA Vaccine Given Intramuscularly (IM) in HIV-1 Uninfected Adults

NCT00043511•National Institute of Allergy and Infectious Diseases (NIAID)

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

HIV Infections

Interventions

pGA2/JS2 Plasmid DNA Vaccine

Locations

4

United States

Locations (4)

Alabama Vaccine CRS

Birmingham, Alabama, United States

UCSF, Gen. Clinical Research Ctr., Mt. Zion Hosp.

San Francisco, California, United States

San Francisco Vaccine and Prevention CRS

San Francisco, California, United States

FHCRC/UW Vaccine CRS

Seattle, Washington, United States

Key Dates

Completion Date

April 1, 2003

Last Updated

October 14, 2021

Related Studies

SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant Families

NCT06627764

Substance AbuseIntimate Partner Violence (IPV)+3 more

Skeletal Muscle Energetics and Fatiguability in Older Individuals

NCT04142047

HIVHIV Infections

RECRUITINGPhase 3

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

NCT06694805

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV

NCT07428330

Cervix CancerHIV Infections+1 more

WiseApp for Spanish Speakers Living With HIV

NCT05398185

HIV InfectionsAcquired Immune Deficiency Syndrome+1 more

Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR)

NCT07225530

HIV InfectionsHPV Infection+1 more

View all related studies

Sponsors

Lead Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 14, 2021Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions